GlobalRPh Renal Dosing Masterv6.6
GlobalRPh source record

Ampicillin

Omnipen

READ THE SOURCE-SPECIFIC ANSWER

Renal guidance at a glance

Confirm the product, indication and renal measure. The selected summary is not a complete prescribing monograph.

Choose a source to read (2)

Display order is not a clinical ranking. Date of retrieval is not the label revision date. Sources are never merged into one regimen. Other sources and conflicts remain below.

Professional source

Stanford adult Ampicillin

Product / population
Adult institutional dosing; not a manufacturer-label replacement.
Renal measure
Not specified; verify before use

Source-specific regimen

Limits that apply to these rows

The printed source leaves exactly 50 unassigned. This is retained Stanford guidance, not a new source retrieval.

Meningitis / endovascular / prosthetic joint infection - IV
CrCl, mL/minSource-specific dose / instruction
>502 g every 4 hours
30 to <502 g every 6 hours
15 to <302 g every 8 hours
<152 g every 12 hours
Read the retained text before reformatting

Meningitis/endovascular/PJI: 2 g IV every 4 / 6 / 8 / 12 hours at CrCl >50 / 30 to <50 / 15 to <30 / <15 mL/min. The printed bands leave exactly 50 unassigned.

Source revision: Antibiotic Subcommittee approved August 2026 | Retrieved: 2026-09-05. Retrieval date is not the revision date.

Source: https://med.stanford.edu/content/dam/sm/bugsanddrugs/documents/antimicrobial-dosing-protocols/SHC-ABX-Dosing-Guide.pdf

Scope: Source-read local summary; source-specific recommendations are not automatically interchangeable. GlobalRPh v6.6.

Full source card / provenance

All sources, comparison tools and evidence navigation
Source-first renal review

Evidence sources and renal implications

Choose a source to jump directly to its locally stored result. Qualitative precautions and evidence gaps remain visible even when no numerical clearance schedule is supplied.

Preserved GlobalRPh source

Preserved original GlobalRPh source

Preserved historical content; not revalidated as current prescribing guidance.

Renal method: Read the measure and population stated in the original source sections.
Retrieved: 2026-09-05

Source presence is not independent validation. A label mirror is not a second independent source; review the original reference and exact formulation.

Find text within this drug
Find a term without leaving this drug

Search the stored clinical text

Locate a word or phrase within this drug's source summaries. Choose all sources or one source to focus the search. The selection never hides warnings or source text, changes a dose, or proves that a renal finding is absent.

Find:

Enter at least two characters. Searches stay on this page and are not saved or sent.

All source summaries, original wording and provenance
Before applying a renal protocol

Check the setting. Compare whole sources.

No patient-specific dose is calculated. Context choices only display reminders; they do not validate, hide or change any regimen.

Share a reproducible source review

Choose sources below, then open a print-ready comparison with product scope, renal method, dates and cautions. Links can pin the exact local cards; they never contain patient values or choose a dose.

Open / share selected sources

Select two distinct source versions. The complete stored summaries will appear below.

Build a source-review outline for documentation

This creates a blank decision outline with the source identities you select, not a dose recommendation or completed clinical assessment. No patient fields are collected, saved or sent. Complete the clinical decisions in your approved documentation system.

Choose one or two sources above or use the source checkboxes below.

Renal-context checklist: population, kidney trend and dialysis

These prompts are a reading aid, not a prescription checklist or proof that all requirements have been met. No selections are stored or sent to a server.

Read the exact source scope, renal metric and date before selecting a row. No applicability assessment has been performed.

See source-specific renal methods and the clinical interpretation guide for the supporting context.

Go directly to the relevant source section

Renal dosing and precautions

Choose a source, then jump to its renal or dialysis section. These links locate stored text; they do not merge regimens or certify that sources agree.

Professional source

Stanford adult Ampicillin

Adult institutional dosing; not a manufacturer-label replacement.

Method: Not stated in selected source.

No dialysis or renal heading shown? Read the complete source summary. Absence of a heading is not evidence that dose adjustment is unnecessary.

Compare or copy source versions

All content below is stored locally. Read a whole source version; do not combine its dose with another source's interval, renal metric or dialysis assumptions.

Choose two source checkboxes below.
Historical source content is not a current prescription. Original GlobalRPh recommendations are preserved, not automatically certified as current. Product-label and professional additions below are separately attributed. Confirm indication, population, kidney-function method, monitoring and the full prescribing information before applying a regimen.
Locally stored source content

Original GlobalRPh protocol

Clinical facts and comments transcribed into a structured reading format. This is not a byte-for-byte HTML archive. Original source: https://globalrph.com/renal/ampicillin/

Usual Dosing (Adults)

(IV): 500mg to 2 grams IV q4-6h.

[Severe infection]: 2 grams IV q4h (150-200mg/kg/day).

(Oral): 250mg to 500mg orally q6h (50-100mg/kg/day).

DOSAGE AND ADMINISTRATION

ADULTS AND CHILDREN WEIGHING OVER 20 KG:

For genitourinary or gastrointestinal tract infections other than gonorrhea in men and women, the usual dose is 500 mg qid in equally spaced doses; severe or chronic infections may require larger doses. For the treatment of gonorrhea in both men and women, a single oral dose of 3.5 grams of ampicillin administered simultaneously with 1 gram of probenecid is recommended. Physicians are cautioned to use no less than the above recommended dosage for the treatment of gonorrhea.

Follow-up cultures should be obtained from the original site(s) of infection 7 to 14 days after therapy. In women, it is also desirable to obtain culture test-of-cure from both the endocervical and anal canals. Prolonged intensive therapy is needed for complications such as prostatitis and epididymitis. For respiratory tract infections, the usual dose is 250 mg qid in equally spaced doses.

CHILDREN WEIGHING 20 KG OR LESS:

For genitourinary or gastrointestinal tract infections, the usual dose is 100 mg/kg/day total, qid in equally divided and spaced doses. For respiratory infections, the usual dose is 50 mg/kg/day total, in equally divided and spaced doses three to four times daily. Doses for children should not exceed doses recommended for adults.

ALL PATIENTS, IRRESPECTIVE OF AGE AND WEIGHT:

Larger doses may be required for severe or chronic infections. Although ampicillin is resistant to degradation by gastric acid, it should be administered at least one-half hour before or two hours after meals for maximal absorption. Except for the single dose regimen for gonorrhea referred to above, therapy should be continued for a minimum of 48 to 72 hours after the patient becomes asymptomatic or evidence of bacterial eradication has been obtained.

In infections caused by hemolytic strains of streptococci, a minimum of 10 days' treatment is recommended to guard against the risk of rheumatic fever of glomerulonephritis. In the treatment of chronic urinary or gastrointestinal infections, frequent bacteriologic and clinical appraisal is necessary during therapy and may be necessary for several months afterwards. Stubborn infections may require treatment for several weeks. Smaller doses than those indicated above should not be used.

GRPH-ampicillin-01 · Source section: Usual Dosing (Adults)Renal section finder

Renal Dosing

Oral / IV:

[CRCL >50]: no change.

[30-49 ml/min]: q6-8 hours.

[10-29 ml/min]: q8-12 hours.

[<10 ml/min]: q12-24 hours.

GRPH-ampicillin-02 · Source section: Renal DosingRenal section finder

Hemodialysis

[<10 ml/min]: Give usual dose every 12-24 hours. Schedule dose after dialysis on dialysis days.

GRPH-ampicillin-03 · Source section: HemodialysisRenal section finder
Separate professional-source layer

University and professional protocols

Professional

Stanford adult Ampicillin

Open original reference

Open / share this exact local source

Stanford Antimicrobial Safety and Sustainability Program · Adult institutional dosing; not a manufacturer-label replacement.

Renal method: Not specified in this summary.
Source date: Antibiotic Subcommittee approved August 2026
Retrieved: 2026-09-05

Source-read local summary; source-specific recommendations are not automatically interchangeable.

Source-specific regimen

Limits that apply to these rows

The printed source leaves exactly 50 unassigned. This is retained Stanford guidance, not a new source retrieval.

Meningitis / endovascular / prosthetic joint infection - IV
CrCl, mL/minSource-specific dose / instruction
>502 g every 4 hours
30 to <502 g every 6 hours
15 to <302 g every 8 hours
<152 g every 12 hours
Read the retained text before reformatting

Meningitis/endovascular/PJI: 2 g IV every 4 / 6 / 8 / 12 hours at CrCl >50 / 30 to <50 / 15 to <30 / <15 mL/min. The printed bands leave exactly 50 unassigned.

ampicillin:stanford-ampicillin-1 · Source locator: PDF page 2, Ampicillin row

Source identity and provenance
Source
https://med.stanford.edu/content/dam/sm/bugsanddrugs/documents/antimicrobial-dosing-protocols/SHC-ABX-Dosing-Guide.pdf
Retrieved
2026-09-05
Source date/version
Antibiotic Subcommittee approved August 2026
Hash meaning
Locally authored source summary, not original SPL/XML/PDF bytes
Local summary SHA-256
4dd0ca5af2cda73bb886586b1f6eb03a15c9673340de1fe5b644bf56e40e1a4d

Provenance and preservation

Additional summaries stored on this page: 0 official-label, 0 RX List, 1 professional, 0 handbook. Empty additional-source groups are not shown. A missing layer is not a no-adjustment recommendation.

Original source
https://globalrph.com/renal/ampicillin/
Source retrieval
2026-09-05. This is not the source publication or label revision date.
Original source type
globalrph individual
Local text SHA-256
d94a3e4773582042a7491bb4bee968372cabfa9ec47d76318bbc9440c23caf7e
Import versus clinical validation
Source-section locators identify where retained content came from. A source-section identifier does not assert that every numeric statement has been independently corroborated. The local text hash is not a hash of original HTML, an FDA PDF or SPL XML.

The original individual GlobalRPh pages commonly cite NIH/NLM DailyMed and instruct readers to review the applicable package insert for updates. That historical reference is preserved as context; it is not counted as an independently retrieved current label.

Read the full coverage report